Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Alladapt Immunotherapeutics, Inc. logo — A biopharmaceutical company developing prescription therapie...

Alladapt Immunotherapeutics, Inc.

A biopharmaceutical company developing prescription therapies for unmet needs in the field of Food Allergy

Founded 2018 United States Menlo Park, United States 7 employees Debt Financing Total: $229.00M Biotechnology

General Information

Company Name Alladapt Immunotherapeutics, Inc.
Founded Year 2018
Location United States Menlo Park, United States +1
Employees 7
Industries Biotechnology
Funding Stage Debt Financing
Social

Get notified when Alladapt Immunotherapeutics, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Alladapt Immunotherapeutics, Inc.

Alladapt Immunotherapeutics, Inc. is a biopharmaceutical company focused on developing prescription therapies for unmet needs in the field of Food Allergy. Founded in 2018 and headquartered in the United States, the company has recently secured a significant $50.00M Debt Financing investment from Hercules Capital on 30 August 2022. Alladapt's dedication to addressing the unmet needs in the field of food allergy indicates its potential for providing innovative and impactful solutions in the biotechnology industry. With this recent investment, the company is poised to further its development of essential therapies, positioning itself as a promising player in the biopharmaceutical sector.

Taxonomy: biopharmaceutical, prescription therapies, food allergy, healthcare industry, medical research, clinical trials, drug development, pharmaceutical industry

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• 1
Investor
30 Aug 2022
Venture Round •••••• 6
Investor Investor Investor Investor Investor
•••• •••• 		22 Jun 2022
Series C •••••• 3
Investor
•••• •••• 		20 Feb 2020

Alladapt Immunotherapeutics, Inc. Alternatives & Competitors

Alladapt Immunotherapeutics, Inc. vs
Ochre Media Pvt Ltd
Ochre Media Pvt Ltd India

Where knowledge talks Business

239 employees
Advertising, B2B
Alladapt Immunotherapeutics, Inc. vs
Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited India

Where Enzyme Is Life.

Post Ipo Equity
294 employees
Biotechnology, Manufacturing
Alladapt Immunotherapeutics, Inc. vs
MASIA COMPRESSORS
MASIA COMPRESSORS United States

PNEUMA... MOVING AIR

3 employees
Manufacturing, Retail

FAQ About Alladapt Immunotherapeutics, Inc.

A biopharmaceutical company developing prescription therapies for unmet needs in the field of Food Allergy
Alladapt Immunotherapeutics, Inc. was founded in 2018.
Alladapt Immunotherapeutics, Inc. is headquartered in Menlo Park, United States.
Alladapt Immunotherapeutics, Inc. operates in the following industries: Biotechnology.
Alladapt Immunotherapeutics, Inc. has approximately 7 employees.
Alladapt Immunotherapeutics, Inc. has completed 3 funding rounds, raising a total of $229.00M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Alladapt Immunotherapeutics, Inc. include Ochre Media Pvt Ltd, Advanced Enzyme Technologies Limited, MASIA COMPRESSORS, SPER Market Research®, Arrow Machine And Fabrication Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alladapt Immunotherapeutics, Inc. and Ochre Media Pvt Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Alladapt Immunotherapeutics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes